Linking hydroxychloroquine to hemolysis in a 'suspected' glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal.
作者信息
Afra T P, Nampoothiri Ram Vasudevan, Razmi T Muhammed, Hafi N A Bishurul
机构信息
Department of Dermatology, IQRAA Aesthetics, IQRAA International Hospital, and Research Centre, Calicut, Kerala, INDIA.
Department of Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, CANADA.
出版信息
Eur J Intern Med. 2020 Oct;80:101-102. doi: 10.1016/j.ejim.2020.07.001. Epub 2020 Jul 7.
Abstract
摘要
相似文献
1
Linking hydroxychloroquine to hemolysis in a 'suspected' glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal.在一名“疑似”葡萄糖-6-磷酸脱氢酶缺乏的COVID-19感染患者中，将羟氯喹与溶血联系起来——一项批判性评估。
Eur J Intern Med. 2020 Oct;80:101-102. doi: 10.1016/j.ejim.2020.07.001. Epub 2020 Jul 7.
2
Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out.在接受羟氯喹/氯喹治疗的COVID-19患者中，葡萄糖-6-磷酸脱氢酶缺乏症相关的溶血：新病例报告问世。
Eur J Intern Med. 2020 Oct;80:103. doi: 10.1016/j.ejim.2020.08.015. Epub 2020 Aug 13.
3
COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency.COVID-19 感染和羟氯喹治疗导致葡萄糖-6-磷酸脱氢酶缺乏症患者发生严重溶血性危机。
Eur J Haematol. 2020 Sep;105(3):357-359. doi: 10.1111/ejh.13432. Epub 2020 May 7.
4
A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine.葡萄糖-6-磷酸脱氢酶缺乏症 COVID-19 患者接受羟氯喹后发生严重溶血的病例报告。
Infect Dis (Lond). 2020 Sep;52(9):659-661. doi: 10.1080/23744235.2020.1774644. Epub 2020 Jun 4.
5
Glucose-6-phosphate dehydrogenase deficiency-associated hemolysis and methemoglobinemia in a COVID-19 patient treated with chloroquine.一名接受氯喹治疗的COVID-19患者出现葡萄糖-6-磷酸脱氢酶缺乏相关的溶血和高铁血红蛋白血症。
Am J Hematol. 2020 Aug;95(8):E194-E196. doi: 10.1002/ajh.25862. Epub 2020 Jun 18.
6
The emergence of methemoglobinemia amidst the COVID-19 pandemic.新冠疫情期间高铁血红蛋白血症的出现。
Am J Hematol. 2020 Aug;95(8):E196-E197. doi: 10.1002/ajh.25868. Epub 2020 Jun 3.
7
The friendly use of chloroquine in the COVID-19 disease: a warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene.氯喹在新冠病毒疾病中的不当使用：对葡萄糖-6-磷酸脱氢酶（G6PD）缺乏的男性及G6PD基因致病性改变的未察觉携带者的警示
Clin Chem Lab Med. 2020 Jun 25;58(7):1162-1164. doi: 10.1515/cclm-2020-0442.
8
Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19.使用氯喹和羟氯喹治疗COVID-19的心血管安全性最新研究结果
Am J Cardiol. 2020 Sep 1;130:162-163. doi: 10.1016/j.amjcard.2020.06.003. Epub 2020 Jun 9.
9
Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine.静脉注射N-乙酰半胱氨酸对重症新型冠状病毒肺炎感染进行炎症的治疗性阻断。
Clin Immunol. 2020 Oct;219:108544. doi: 10.1016/j.clim.2020.108544. Epub 2020 Jul 22.
10
Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA).葡萄糖-6-磷酸脱氢酶（G6PD）缺乏的新冠肺炎患者使用羟氯喹（HCQ）及急性溶血性贫血（AHA）风险
Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):7923-7924. doi: 10.26355/eurrev_202008_22473.
引用本文的文献
1
Hematologic Outcomes of COVID-19 Patients with and without G6PD Deficiency: A Comparative Study.伴有和不伴有葡萄糖-6-磷酸脱氢酶（G6PD）缺乏的COVID-19患者的血液学结果：一项比较研究。
Qatar Med J. 2022 Nov 16;2022(4):54. doi: 10.5339/qmj.2022.54. eCollection 2022.
2
The Affinity of Hemoglobin for Oxygen Is Not Altered During COVID-19.新冠病毒感染期间血红蛋白对氧气的亲和力未发生改变。
Front Physiol. 2021 Apr 12;12:578708. doi: 10.3389/fphys.2021.578708. eCollection 2021.
3
Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out.在接受羟氯喹/氯喹治疗的COVID-19患者中，葡萄糖-6-磷酸脱氢酶缺乏症相关的溶血：新病例报告问世。
Eur J Intern Med. 2020 Oct;80:103. doi: 10.1016/j.ejim.2020.08.015. Epub 2020 Aug 13.
4
Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection.羟氯喹在新冠大流行时代：为了合理预防 SARS-CoV-2 感染而进行的探索。
Expert Rev Anti Infect Ther. 2021 Jan;19(1):5-16. doi: 10.1080/14787210.2020.1799785. Epub 2020 Aug 16.
本文引用的文献
1
Hydroxychloroquine use in COVID-19: what is the basis for baseline tests?羟氯喹在新型冠状病毒肺炎中的应用：基线检测的依据是什么？
Lancet Infect Dis. 2020 Oct;20(10):1120-1121. doi: 10.1016/S1473-3099(20)30472-2. Epub 2020 Jun 16.
2
Doubtful precipitation of hemolysis by hydroxychloroquine in glucose-6-phosphate dehydrogenase-deficient patient with COVID-19 infection.葡萄糖-6-磷酸脱氢酶缺乏的新冠肺炎患者使用羟氯喹引发溶血的可能性存疑。
Eur J Haematol. 2020 Oct;105(4):512-513. doi: 10.1111/ejh.13460. Epub 2020 Jul 2.
3
Acute hemolysis by hydroxycloroquine was observed in G6PD-deficient patient with severe COVD-19 related lung injury.在一名患有严重COVID-19相关肺损伤的葡萄糖-6-磷酸脱氢酶（G6PD）缺乏症患者中，观察到羟氯喹引起的急性溶血。
Eur J Intern Med. 2020 Jul;77:136-137. doi: 10.1016/j.ejim.2020.04.020. Epub 2020 Apr 20.
4
COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency.COVID-19 感染和羟氯喹治疗导致葡萄糖-6-磷酸脱氢酶缺乏症患者发生严重溶血性危机。
Eur J Haematol. 2020 Sep;105(3):357-359. doi: 10.1111/ejh.13432. Epub 2020 May 7.
5
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.严重 COVID-19 感染发病机制中的补体相关微血管损伤和血栓形成：五例报告。
Transl Res. 2020 Jun;220:1-13. doi: 10.1016/j.trsl.2020.04.007. Epub 2020 Apr 15.
6
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.氯喹治疗后有无伯氨喹治疗对间日疟原虫疟疾的血液学后果：全球抗疟药物耐药网络系统评价和个体患者数据荟萃分析。
BMC Med. 2019 Aug 1;17(1):151. doi: 10.1186/s12916-019-1386-6.
7
Examination of Hydroxychloroquine Use and Hemolytic Anemia in G6PDH-Deficient Patients.检查葡萄糖-6-磷酸脱氢酶（G6PDH）缺乏患者中羟氯喹的使用与溶血性贫血。
Arthritis Care Res (Hoboken). 2018 Mar;70(3):481-485. doi: 10.1002/acr.23296. Epub 2018 Feb 9.
8
Enhanced Eryptosis Following Exposure to Lopinavir.洛匹那韦暴露后增强的红细胞凋亡
Cell Physiol Biochem. 2015;37(6):2486-95. doi: 10.1159/000438601. Epub 2015 Dec 17.
9
Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.药物与葡萄糖-6-磷酸脱氢酶缺乏：循证综述。
Drug Saf. 2010 Sep 1;33(9):713-26. doi: 10.2165/11536520-000000000-00000.
Zotero 插件